Since CDC5L protein was demonstrated to act as a positive regulator of cell cycle G2/M progression,32 we compared the relationship between CDC5L expression levels and six classical cytogenetic abnormalities and evaluated the impacts of CDC5L expression on survival of MM patients in the MMRF dataset. This evidence concerns the gene CDC5L and Miyoshi myopathy.